BioTech Weekly

🚀 Biotech & Life Sciences Weekly Highlights 🌱 Privacy Under Fire: 27 states and D.C. are suing 23andMe to stop the sale of personal genetic data without consent — as Regeneron eyes acquisition during bankruptcy proceedings.Organoid Innovation: Pluristyx launches the PluriForm™ Organoid Kit, dramatically cutting down organoid development timelines with ready-to-differentiate iPSCs.Funding Milestone: Genesys Capital closes its largest fund yet — Genesys Ventures IV LP — backing Canadian

🚀 This week’s podcast covers a wide range of Biotech updates 🧬 Topics include a new gene-editing therapy used in a rare pediatric case, progress in cell sorting technologies, and recent patent activity in therapeutic development. If you’re looking for a brief, clear summary of what’s happening in the space, this episode offers a helpful overview. 🎧 Listen here. #Biotech #LifeSciences #GeneTherapy #CRISPR #Healthcare #IndustryUpdate #Podcast #AI #NotebookLM Sources: Baby saved by gene-ed...